Export program Germany

Through the Norwegian government's export reform, HealthCatalyst provides Norwegian companies with advisory services, networks, and activities to strengthen their position in the German health market

A Collaborative Initiative for Health Export Growth

HealthCatalyst, (Norway Health Tech, Oslo Cancer Cluster, Validé (Norwegian Smart Care Cluster)), and The Life Science Cluster, has been tasked with leading the government's health initiative in Germany under the export reform program "The Whole of Norway Exports". Germany has been identified as a key market for Norwegian health tech companies looking to increase exports. The project focuses on specific companies with existing export revenues aiming to expand their market share, defined as the ‘landslagsliste’ by Innovation Norway.

Ministerbesøk i Berlin
Jutta Heix, Helse og omsorgsminister Jan Christian Vestre, Arild Kristensen

Targeted Support for Norwegian Companies

Based on input from one to one interviews with all the companies on the ‘landslagsliste’, HealthCatalyst have in collaboration with Innovation Norway and Team Norway in Germany launched several initiatives, organized into the following areas:


1. Market Entry Barriers and Roadmap (Workpackage 1)
Please save the dates for our upcoming webinar and workshop series (calendar invites and detailed invitations will follow):

  • June 4, 2025 | 11:30–12:45 (Webinar): Understanding the German Healthcare System: Structures, Changes & Implications - Material from the meeting can be found here!
  • Sept 24, 2025 | 11:30–12:45 (Webinar): Regulatory Landscape: DIGA & Hospital Reform
  • Oct 16, 2025 (Berlin): High-Level Roundtable Meeting (Topic TBD)
  • Nov 5, 2025 | 11:30–12:45 (Webinar): Reimbursement System: Changes & Strategies to Address Underfunding
  • Dec 4, 2025 | 15:00–20:00 (In-Person Workshop): Boosting Sales Expertise & Success, followed by networking

2. Industry Events & Side Programs (Workpackage 2)
Join us at key industry events, which will include receptions and side events:

  • Minister meeting in Berlin at Charité and the Norwegian Ambassadors residence, January 28-29 in Berlin
  • DMEA: April 8-10, 2025, Berlin (Pavillion at the conference and Nordic Night event at the Nordic House)
  • ESMO: Oct 17–21, 2025, Berlin (Satellite Program & Reception)
  • BioEurope: Nov 3–5, 2025, Vienna (TBC)
  • Medica: Nov 17–20, 2025, Düsseldorf (Side event)
    More details will follow via email.

3. Study Trips & Delegation Visits (Workpackage 3)
To tailor meaningful visits, we need your input. Let us know:

  • Who would you like to meet in Germany and/or host in Norway?
  • Suggestions for study trips or other formats opening novel doors that will bring value to you company

We are happy to set up a short call to discuss your ideas.

4. Framework Conditions in the Norwegian market.
We have shared your concerns with Innovation Norway and InvestIN. While this is a secondary part of the project, we recognize its importance and will continue advocating for better framework conditions building on your input.

We are looking forward to continuing our collaboration, please call or mail with questions or suggestions to:

Project manager: Arild Kristensen, Norway Health Tech, arild.kristensen@norwayhealthtech.com, +47 90532591

Jutta Heix, Oslo Cancer Cluster, jh@oslocancercluster.no +47 94163089

Trine Radmann, Norway Health Tech, trine.radmann@norwayhealthtech.com + 47 99269285